Trial · NCT04818346
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 24-Week Placebo-controlled Period | STARTED | Placebo | 43 | |
| 24-Week Placebo-controlled Period | STARTED | Povorcitinib 15 mg | 43 | |
| 24-Week Placebo-controlled Period | STARTED | Povorcitinib 45 mg | 43 | |
| 24-Week Placebo-controlled Period | STARTED | Povorcitinib 75 mg | 42 | |
| 24-Week Placebo-controlled Period | COMPLETED | Placebo | 35 | |
| 24-Week Placebo-controlled Period | COMPLETED | Povorcitinib 15 mg | 38 | |
| 24-Week Placebo-controlled Period | COMPLETED | Povorcitinib 45 mg | 32 | |
| 24-Week Placebo-controlled Period | COMPLETED | Povorcitinib 75 mg | 34 | |
| 24-Week Placebo-controlled Period | NOT COMPLETED | Placebo | 8 | |
| 24-Week Placebo-controlled Period | NOT COMPLETED | Povorcitinib 15 mg | 5 | |
| 24-Week Placebo-controlled Period | NOT COMPLETED | Povorcitinib 45 mg | 11 | |
| 24-Week Placebo-controlled Period | NOT COMPLETED | Povorcitinib 75 mg | 8 | |
| 28-Week Double-blind Extension Period | STARTED | Placebo | 35 | |
| 28-Week Double-blind Extension Period | STARTED | Povorcitinib 15 mg | 37 | |
| 28-Week Double-blind Extension Period | STARTED | Povorcitinib 45 mg | 32 | |
| 28-Week Double-blind Extension Period | STARTED | Povorcitinib 75 mg | 34 | |
| 28-Week Double-blind Extension Period | COMPLETED | Placebo | 33 | |
| 28-Week Double-blind Extension Period | COMPLETED | Povorcitinib 15 mg | 30 | |
| 28-Week Double-blind Extension Period | COMPLETED | Povorcitinib 45 mg | 26 | |
| 28-Week Double-blind Extension Period | COMPLETED | Povorcitinib 75 mg | 28 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04818346/flow